With nearly a third of Japan’s population aged at 65 or over, life science and R&D real estate presents a compelling opportunity for property investors seeking to capitalise on rising healthcare demand and increasing pharmaceutical research and development, according to… Read More>>
With nearly a third of Japan’s population aged at 65 or over, life science and R&D real estate presents a compelling … Read more>>>



















